Skip to content
DataLookout
Menu

VOVSNCT03346889

Vestibular Outcomes in Vestibular Schwannoma

StatusUnknown
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 8 versions: 6 with changes below, 2 re-verified with no change.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
  2. Minor Study completion date: Dec 31, 2023 to Dec 31, 2025v8
  3. Minor Primary completion date changed from estimate of Dec 31, 2022 to Jun 25, 2019
    • Study completion date: Dec 31, 2022 to Dec 31, 2023
    v7
  4. Notable Primary and study completion dates: Dec 31, 2021 to Dec 31, 2022v6
  5. Notable Primary and study completion dates: Dec 31, 2019 to Dec 31, 2021
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 150 to confirmed 155
    • Site details revised
    v4
  6. Notable Primary and study completion dates pushed to Dec 31, 2019v3
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Dizziness Handicap Inventory (DHI)
Timeframe: Baseline and 1-year follow-up

Secondary (5)

Vertigo Symptom Scale Short Form
Haukeland Dizziness Questionnaire (HDQ-10)
Vertigo Visual Analog Scale
Hospital Anxiety and Depression Scale (HADS)
RAND-12

Sites

1 site in 1 country

  • Haukeland University HospitalBergen, Hordaland, Norway